|
|||||
|
|
A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention: The SYNTAX Trial at 3 Years |
|
| Authors: | Patrick W. Serruys Vasim Farooq Pascal Vranckx Chrysafios Girasis Salvatore Brugaletta Hector M. Garcia-Garcia David R. Holmes Arie-Pieter Kappetein Michael J. Mack Ted Feldman Marie-Claude Morice Elisabeth Ståhle Stefan James Antonio Colombo Peggy Pereda Jian Huang Marie-Angèle Morel Gerrit-Anne Van Es Keith D. Dawkins Friedrich W. Mohr Ewout W. Steyerberg |
| Affiliation: | 2. The Mayo Clinic, Rochester, Minnesota;3. Department of Cardiothoracic Surgery, Erasmus University, Medical Centre, Thoraxcenter, Rotterdam, the Netherlands;4. Medical City Dallas Hospital, Dallas, Texas;5. Institut Jacques Cartier, Massy, France;11. Boston Scientific Corporation, Natick, Massachusetts;12. Cardialysis BV, Rotterdam, the Netherlands;8. Herzzentrum, Leipzig, Germany |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |